This document discusses recombinant DNA vaccines. It explains that DNA vaccines use genetic material from pathogens to induce an immune response against the pathogen. The genetic material is injected into host cells where it is expressed to produce foreign antigens that the immune system responds to. This induces both antibody and cellular immunity. Recombinant DNA vaccines are considered a third generation of vaccines as they rely on plasmid DNA to produce antigens rather than an inactivated or attenuated pathogen. They have advantages like inducing long-lasting immunity and not requiring refrigeration. However, they can currently only encode protein antigens. Human trials are ongoing for DNA vaccines against diseases like AIDS, influenza, Ebola, and malaria.